INS and Hypoglycemia: In summary, the above observations consistently suggest that liberal glucose control to a target between 10 and 14 mmol/l (180–252 mg/dl) decreases insulin administration requirements, lowers glucose variability, and reduces the risk of hypoglycemia, especially among those patients with poor pre-morbid glycemic control.